About this paper
For its 8th annual Health Care & Life Sciences Executive Conference, SAS brought together great minds from across the industry – provider, pharma, payer and policy segments – to discuss the promise of data and analytics in improving medical decisions, costs and outcomes, particularly as the industry is being reshaped in the U.S. by the Patient Protection and Affordable Care Act. This paper summarizes the Executive Leadership Panel Discussion, which offered insights from various industry perspectives: government, the research and provider communities, and health care IT.
SAS is the leader in business analytics software and services, and the largest independent vendor in the business intelligence market. Through innovative solutions, SAS helps customers at more than 80,000 sites improve performance and deliver value by making better decisions faster. Since 1976 SAS has been giving customers around the world The Power to Know® .